Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $792M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XNCR | XENCOR ORD | 2,501,557 | $84.38M | 10.7% | $35.02 | +14.0% | COM | 98401F105 |
| PRTA | PROTHENA ORD | 9,426,640 | $73.91M | 9.3% | $9.11 | -2.5% | COM | G72800108 |
| — | SPARK THERAPEUTICS ORD | 714,789 | $69.32M | 8.8% | $63.21 | — | COM | 84652J103 |
| KURA | KURA ONCOLOGY ORD | 4,041,953 | $61.32M | 7.7% | $10.87 | +63.7% | COM | 50127T109 |
| ARGX | ARGENX ADR REP ORD | 531,165 | $60.53M | 7.6% | $96.07 | — | SPONSORED ADR | 04016X101 |
| — | DICERNA PHARMACEUTICALS ORD | 3,962,978 | $56.91M | 7.2% | $10.37 | — | COM | 253031108 |
| — | FIBROGEN ORD | 1,293,807 | $47.84M | 6.0% | $44.16 | — | COM | 31572Q808 |
| IRWD | IRONWOOD PHARMA CL A ORD | 4,671,408 | $40.1M | 5.1% | $11.82 | -17.8% | COM | 46333X108 |
| — | MORPHIC HOLDING ORD | 2,161,520 | $39.15M | 4.9% | $19.82 | — | COM | 61775R105 |
| — | SOLID BIOSCIENCES ORD | 3,342,691 | $34.56M | 4.4% | $9.20 | — | COM | 83422E105 |
| — | PREVAIL THERAPEUTICS ORD | 2,392,556 | $29.38M | 3.7% | $13.20 | — | COM | 74140Y101 |
| — | FIBROGEN ORD | 652,500 | $24.13M | 3.0% | $44.16 | — | Call | 31572Q808 |
| — | HARPOON THERAPEUTICS ORD | 1,463,423 | $19.99M | 2.5% | $9.80 | — | COM | 41358P106 |
| — | ATRECA CL A ORD | 1,481,411 | $18.13M | 2.3% | $18.84 | — | COM | 04965G109 |
| — | CHIASMA ORD | 3,043,827 | $15.07M | 1.9% | $5.00 | — | COM | 16706W102 |
| SRPT | SAREPTA THERAPEUTICS ORD | 189,745 | $14.29M | 1.8% | $118.10 | 0.0% | COM | 803607100 |
| — | EXICURE ORD | 5,515,225 | $13.95M | 1.8% | $2.53 | — | COM | 30205M101 |
| GOSS | GOSSAMER BIO INC ORD | 800,000 | $13.43M | 1.7% | $20.85 | -4.6% | Call | 38341P102 |
| — | EIGER BIOPHARMACEUTICAL ORD | 1,060,043 | $10.87M | 1.4% | $11.49 | — | COM | 28249U105 |
| — | CYCLERION THERAPEUTICS ORD | 776,206 | $9.408M | 1.2% | $11.45 | — | COM | 23255M105 |
| — | NEXTCURE ORD | 250,500 | $7.728M | 1.0% | $30.85 | — | COM | 65343E108 |
| RCUS | ARCUS BIOSCIENCES ORD | 754,505 | $6.866M | 0.9% | $14.43 | -44.3% | COM | 03969F109 |
| — | CURIS ORD | 2,982,208 | $6.68M | 0.8% | $0.69 | — | COM | 231269200 |
| — | NEOLEUKIN THERAPEUTICS ORD | 2,265,880 | $6.458M | 0.8% | $2.85 | — | COM | 64049K104 |
| — | ASSEMBLY BIOSCIENCES ORD | 498,300 | $4.898M | 0.6% | $9.83 | — | Call | 045396108 |
| — | MIRATI THERAPEUTICS ORD | 44,221 | $3.445M | 0.4% | $53.32 | — | COM | 60468T105 |
| — | MERUS ORD | 165,600 | $2.951M | 0.4% | $17.82 | — | COM | N5749R100 |
| RARE | ULTRAGENYX PHARMACEUTICAL ORD | 61,554 | $2.633M | 0.3% | $57.14 | -4.9% | COM | 90400D108 |
| — | SURFACE ONCOLOGY ORD | 1,548,888 | $2.199M | 0.3% | $10.23 | — | COM | 86877M209 |
| — | RUBIUS THERAPEUTICS ORD | 260,152 | $2.042M | 0.3% | $23.51 | — | COM | 78116T103 |
| VCEL | VERICEL ORD | 131,001 | $1.983M | 0.3% | $18.29 | -4.3% | COM | 92346J108 |
| — | IGM BIOSCIENCES ORD | 100,000 | $1.775M | 0.2% | $17.75 | — | COM | 449585108 |
| — | ZAFGEN ORD | 1,944,500 | $1.437M | 0.2% | $0.74 | — | COM | 98885E103 |
| QNCX | CORTEXYME ORD | 49,993 | $1.246M | 0.2% | $30.76 | 0.0% | COM | 22053A107 |
| — | ASSEMBLY BIOSCIENCES ORD | 96,600 | $950K | 0.1% | $9.83 | — | COM | 045396108 |
| AUTL | AUTOLUS THERAPEUTICS ADR | 69,155 | $859K | 0.1% | $12.42 | — | SPONSORED ADR | 05280R100 |
| — | REGULUS THERAPEUTICS ORD | 1,049,088 | $755K | 0.1% | $1.25 | — | COM | 75915K200 |
| — | UNITY BIOTECHNOLOGY ORD | 51,400 | $314K | 0.0% | $14.33 | — | COM | 91381U101 |